Cited by 1,898Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisImmune responses and vaccinations

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Open access

Berry, Matthew P. R., Graham, Christine M., McNab, Finlay W., Xu, Zhaohui, Bloch, Susannah A. A., Oni, Tolu, Wilkinson, Katalin A., Banchereau, Romain, Skinner, Jason, Wilkinson, Robert J., Quinn, Charles, Blankenship, Derek, Dhawan, Ranju, Cush, John J., Mejias, Asuncion, Ramilo, Octavio, Kon, Onn M., Pascual, Virginia, Banchereau, Jacques, Chaussabel, Damien, O’Garra, Anne·2010·Nature

DOI 10.1038/nature09247PMC PMC3492754

Open this paper in CoChat — free account

Abstract

Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alphabeta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alphabeta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature09247

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
Baechler, E. C., Batliwalla, F., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M. H., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,246
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L. B., Palucka, K., Arce, E., Cantrell, V., Borvák, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,990
Self-citation
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,744
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V. A., Dick, T., Ehrt, S., Flynn, J. L., Schnappinger, D., Wilkinson, R. J., & Young, D. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,441
Self-citation
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Immunology of tuberculosis.
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 1,006
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Chaussabel, D., Quinn, C., Shen, J., Patel, P., Glaser, C., Baldwin, N., Stichweh, D., Blankenship, D., Li, L., Munagala, I., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.012 · Cited by 649
Self-citation
Immunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636
Tuberculosis. Clinical diagnosis and management of tuberculosis and measures for its prevention and control
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 636

Flagged first, then by citations

Show all 29 references

Research works printed but not linked: 2

Dye, C., Floyd, K. & Uplekar, M. in Global Tuberculosis Control: Surveillance, Planning, Financing Ch. 1, 17–37 (World Health Organization, 2008)
Falk, A. & O’Connor, J. B. in Diagnosis Standards and Classification of Tuberculosis, vol. 12 (eds Falk, A. et al.), 68–76 (National Tuberculosis and Respiratory Disease Association, 1969)

Sorted by citations

Items 201–300 of 1,000

Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis
Kotov, D. I., Lee, O. V., Fattinger, S. A., Langner, C. A., Guillen, J. V., Peters, J. M., Moon, A., Burd, E. M., Witt, K. C., Stetson, D. B., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.002 · Cited by 146
Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells
Lachmandas, E., Bompadre, M. B., Cheng, S., Kumar, V., van Laarhoven, A., Wang, X., Ammerdorffer, A., Boutens, L., de Jong, D., Kanneganti, T., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546259 · Cited by 145
Unifying immunology with informatics and multiscale biology
Kidd, B. A., Peters, L. A., Schadt, E. E., & Dudley, J. T. (2014) · Nature Immunology · doi:10.1038/ni.2787 · Cited by 145
Matrix metalloproteinases in tuberculosis
Elkington, P. T., Ugarte‐Gil, C., & Friedland, J. S. (2011) · European Respiratory Journal · doi:10.1183/09031936.00015411 · Cited by 142
New pathways of protective and pathological host defense to mycobacteria
Ottenhoff, T. H. M. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.06.002 · Cited by 143
IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions
Rühwald, M., Aabye, M. G., & Ravn, P. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.97 · Cited by 139
Tuberculosis susceptibility and protection in children
Roy, R. B., Whittaker, E., Seddon, J. A., & Kampmann, B. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30157-9 · Cited by 148
Tuberculosis Diagnostics: State of the Art and Future Directions
Pai, M., Nicol, M. P., & Boehme, C. C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0019-2016 · Cited by 138
Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
Ndlovu, H., & Marakalala, M. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00434 · Cited by 142
Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases
Irvine, E. B., & Alter, G. (2020) · Glycobiology · doi:10.1093/glycob/cwaa018 · Cited by 143
Inflammation in tuberculosis: interactions, imbalances and interventions
Kaufmann, S. H. E., & Dorhoi, A. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.005 · Cited by 138
Pattern Recognition Receptors and Cytokines inMycobacterium tuberculosisInfection—The Double-Edged Sword?
Hossain, M. M., & Norazmi, M. N. (2013) · BioMed Research International · doi:10.1155/2013/179174 · Cited by 146
Identification of a human neonatal immune-metabolic network associated with bacterial infection
Smith, C., Dickinson, P., Forster, T., Craigon, M., Ross, A., Khondoker, M. R., France, R., Ivens, A. C., Lynn, D. J., Orme, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5649 · Cited by 134
Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway
Redford, P. S., Mayer-Barber, K. D., McNab, F. W., Stavropoulos, E., Wack, A., Sher, A., & O’Garra, A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit424 · Cited by 136
Self-citation
STING-Dependent Type I IFN Production Inhibits Cell-Mediated Immunity to Listeria monocytogenes
Archer, K. A., Durack, J., & Portnoy, D. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003861 · Cited by 137
Concise gene signature for point‐of‐care classification of tuberculosis
Maertzdorf, J., McEwen, G. K., Weiner, J. M., Tian, S., Lader, E., Schriek, U., Mayanja‐Kizza, H., Ota, M. O. C., Kenneth, J., & Kaufmann, S. H. E. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505790 · Cited by 133
Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis
Cheng, C. Y., Gutierrez, N. M., Marzuki, M., Lu, X., Foreman, T. W., Paleja, B. S., Lee, B. T. K., Balachander, A., Chen, J., Tsenova, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj1789 · Cited by 138
Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response
Warsinske, H., Rao, A., Moreira, F. M. F., dos Santos, P. C. P., Liu, A. B., Scott, M. K. D., Malherbe, S. T., Ronacher, K., Walzl, G., Winter, J. A., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3779 · Cited by 133
Point of care diagnostics for tuberculosis
García‐Basteiro, A. L., DiNardo, A. R., Saavedra, B., Silva, D. R., Palmero, D., Gegia, M., Migliori, G. B., Duarte, R., Mambuque, E., Centis, R., et al. (2018) · Pulmonology · doi:10.1016/j.rppnen.2017.12.002 · Cited by 132
Type I interferons in host defence and inflammatory diseases
Crow, M. K., & Rönnblom, L. (2019) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000336 · Cited by 134
Type I interferon decreases macrophage energy metabolism during mycobacterial infection
Olson, G. S., Murray, T. A., Jahn, A. N., Mai, D., Diercks, A. H., Gold, E. S., & Aderem, A. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109195 · Cited by 131
Quest for Correlates of Protection against Tuberculosis
Bhatt, K., Verma, S., Ellner, J. J., & Salgame, P. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00721-14 · Cited by 134
Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions betweenMycobacterium tuberculosisand Innate Immune Cells
Sia, J. K., Georgieva, M., & Rengarajan, J. (2015) · Journal of Immunology Research · doi:10.1155/2015/747543 · Cited by 140
Early Changes by 18 Fluorodeoxyglucose Positron Emission Tomography Coregistered with Computed Tomography Predict Outcome after Mycobacterium tuberculosis Infection in Cynomolgus Macaques
Coleman, M. T., Maiello, P. A., Tomko, J. A., Frye, L. J., Fillmore, D. J., Janssen, C., Klein, E. C., & Lin, P. L. (2014) · Infection and Immunity · doi:10.1128/iai.01599-13 · Cited by 127
Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis
Moreira-Teixeira, L., Tabone, O., Graham, C. M., Singhania, A., Stavropoulos, E., Redford, P. S., Chakravarty, P., Priestnall, S. L., Suarez-Bonnet, A., Herbert, E., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0610-z · Cited by 127
Self-citation
Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
Naranbhai, V., Hill, A. V. S., Karim, S. S. A., Naidoo, K., Karim, Q. A., Warimwe, G. M., McShane, H., & Fletcher, H. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit494 · Cited by 132
The End of the Binary Era: Revisiting the Spectrum of Tuberculosis
Lin, P. L., & Flynn, J. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800993 · Cited by 126
Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection
Gröschel, M. I., Sayes, F., Shin, S. J., Frigui, W., Pawlik, A., Orgeur, M., Canetti, R., Honoré, N., Simeone, R., van der Werf, T. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.057 · Cited by 125
Macrophage immunoregulatory pathways in tuberculosis
Rajaram, M. V. S., Ni, B., Dodd, C. E., & Schlesinger, L. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.010 · Cited by 131
Lung necrosis and neutrophils reflect common pathways of susceptibility toMycobacterium tuberculosisin genetically diverse, immune competent mice
Niazi, M. K. K., Dhulekar, N., Schmidt, D., Major, S., Cooper, R., Abeijón, C., Gatti, D. M., Kramnik, I., Yener, B., Gürcan, M. N., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020867 · Cited by 128
Type I Interferon Transcriptional Signature in Neutrophils and Low-Density Granulocytes Are Associated with Tissue Damage in Malaria
Rocha, B. C., Marques, P. E., Leoratti, F. M. S., Junqueira, C., Pereira, D. B., Antonelli, L. R. D. V., Menezes, G. B., Golenbock, D. T., & Gazzinelli, R. T. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.055 · Cited by 127
The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis
Singhania, A., Wilkinson, R. J., Rodrigue, M., Haldar, P., & O’Garra, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0225-9 · Cited by 126
Self-citation
Gene expression profiles in febrile children with defined viral and bacterial infection
Hu, X., Yu, J., Crosby, S. D., & Storch, G. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302968110 · Cited by 123
Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis
Mahasirimongkol, S., Yanai, H., Mushiroda, T., Promphittayarat, W., Wattanapokayakit, S., Phromjai, J., Yuliwulandari, R., Wichukchinda, N., Yowang, A., Yamada, N., et al. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.35 · Cited by 123
Sensing of M ycobacterium tuberculosis and consequences to both host and bacillus
Stamm, C. E., Collins, A. C., & Shiloh, M. U. (2015) · Immunological Reviews · doi:10.1111/imr.12263 · Cited by 131
Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications
Prada‐Medina, C. A., Fukutani, K. F., Kumar, N. P., Gil-Santana, L., Babu, S., Lichtenstein, F., West, K., Sivakumar, S., Menon, P. A., Viswanathan, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01767-4 · Cited by 124
Rab GTPases in Immunity and Inflammation
Prashar, A., Schnettger, L., Bernard, E. M., & Gutierrez, M. G. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00435 · Cited by 126
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects
Lachmandas, E., Eckold, C., Böhme, J., Koeken, V. A. C. M., Marzuki, M., Blok, B. A., Arts, R. J. W., Chen, J., Teng, K. W. W., Ratter, J. M., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz064 · Cited by 122
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis
Das, R., Koo, M.-S., Kim, B.-H., Jacob, S. T., Subbian, S., Yao, J., Leng, L., Levy, R., Murchison, C., Burman, W. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301128110 · Cited by 121
LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis
Weindel, C. G., Bell, S. L., Huntington, T. E., Vail, K. J., Srinivasan, R., Patrick, K. L., & Watson, R. O. (2020) · eLife · doi:10.7554/elife.51071 · Cited by 124
Alveolar macrophages and type I IFN in airway homeostasis and immunity
Divangahi, M., King, I. L., & Pernet, E. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.03.005 · Cited by 127
Inflammation and tuberculosis: host‐directed therapies
Zumla, A. I., Rao, M., Parida, S. K., Keshavjee, S. A., Cassell, G. H., Wallis, R. S., Axelsson‐Robertson, R., Doherty, M. T., Andersson, J., & Maeurer, M. J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12256 · Cited by 120
Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse Models
Fenaroli, F., Repnik, U., Xu, Y., Johann, K., Herck, S. V., Dey, P., Skjeldal, F. M., Frei, D. M., Bagherifam, S., Kocere, A., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b04433 · Cited by 121
Mycobacterium tuberculosis –induced IFN-β production requires cytosolic DNA and RNA sensing pathways
Cheng, Y., & Schorey, J. S. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180508 · Cited by 122
Increased Complement C1q Level Marks Active Disease in Human Tuberculosis
Cai, Y., Yang, Q., Tang, Y., Zhang, M., Liu, H., Zhang, G., Deng, Q., Huang, J., Gao, Z., Zhou, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092340 · Cited by 119
Host-Directed Therapies for Tuberculosis: Figure 1.Preprint
Tobin, D. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021196 · Cited by 123
Chemokines in tuberculosis: The good, the bad and the ugly
Monin, L., & Khader, S. A. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.004 · Cited by 121
Host defense mechanisms against Mycobacterium tuberculosis
Chai, Q., Lü, Z., & Liu, C. H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03353-5 · Cited by 125
Type I interferons in bacterial infections: A balancing act
Kovarik, P., Castiglia, V., Ivin, M., & Ebner, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00652 · Cited by 117
The Immune Response toMycobacterium tuberculosisin HIV-1-Coinfected Persons
Esmail, H., Riou, C., Bruyn, E. D., Lai, R., Harley, Y. X. R., Meintjes, G., Wilkinson, K. A., & Wilkinson, R. J. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053420 · Cited by 117
Self-citation
Fact and fiction in tuberculosis vaccine research: 10 years later
Kaufmann, S. H. E. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70146-3 · Cited by 120
IL-32 is a molecular marker of a host defense network in human tuberculosis
Montoya, D. J., Inkeles, M. S., Liu, P. T., Realegeno, S. E., Teles, R. M. B., Vaidya, P., Munoz, M. A., Schenk, M., Swindell, W. R., Chun, R. F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009546 · Cited by 115
Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection
Huynh, J., Lin, C., Kimmey, J. M., Jarjour, N. N., Schwarzkopf, E. A., Bradstreet, T. R., Shchukina, I., Shpynov, O., Weaver, C. T., Taneja, R., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171704 · Cited by 117
Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions with Aging and Influenza Infection
Bongen, E., Lucian, H. J., Khatri, A., Fragiadakis, G. K., Bjornson, Z. B., Nolan, G. P., Utz, P. J., & Khatri, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.019 · Cited by 116
Neutrophils in type 1 diabetes
Huang, J., Xiao, Y., Xu, A., & Zhou, Z. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12469 · Cited by 114
Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences
Donovan, M. L., Schultz, T. E., Duke, T. J., & Blumenthal, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01633 · Cited by 117
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
Groote, M. A. D., Nahid, P., Jarlsberg, L. G., Johnson, J. L., WEINER, M. H., Muzanyi, G., Janjić, N., Sterling, D. G., & Ochsner, U. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061002 · Cited by 115
Type I interferon signaling mediates Mycobacterium tuberculosis –induced macrophage death
Zhang, L., Jiang, X., Pfau, D. J., Ling, Y., & Nathan, C. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200887 · Cited by 115
Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas
Wang, Y., Sun, Q., Zhang, Y., Li, X., Liang, Q., Guo, R., Zhang, L., Han, X., Wang, J., Shao, L., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.03.020 · Cited by 117
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
McShane, H., & Williams, A. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.11.003 · Cited by 112
The C-Type Lectin Receptor CLECSF8/CLEC4D Is a Key Component of Anti-Mycobacterial Immunity
Wilson, G. J., Marakalala, M. J., Hoving, J. C., van Laarhoven, A., Drummond, R. A., Kerscher, B., Keeton, R., van de Vosse, E., Ottenhoff, T. H. M., Plantinga, T. S., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.004 · Cited by 112
Assessment of immune status using blood transcriptomics and potential implications for global health
Chaussabel, D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.002 · Cited by 114
Self-citation
Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology
Hahn, S., Giaglis, S., Chowdhury, C. S., Hösli, I., & Hasler, P. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0380-x · Cited by 111
Interferon-driven deletion of antiviral B cells at the onset of chronic infection
Fallet, B., Narr, K., Ertuna, Y. I., Remy, M. M., Sommerstein, R., Cornille, K., Kreutzfeldt, M., Pagé, N., Zimmer, G., Geier, F. M., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah6817 · Cited by 111
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
Tiwari, D., & Martineau, A. R. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101672 · Cited by 114
Re‐evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells
Vanwolleghem, T., Hou, J., van Oord, G., Andeweg, A. C., Osterhaus, A. D. M. E., Pas, S. D., Janssen, H. L. A., & Boonstra, A. (2015) · Hepatology · doi:10.1002/hep.27805 · Cited by 110
Programmed death ligand 1 is over‐expressed by neutrophils in the blood of patients with active tuberculosis
McNab, F. W., Berry, M. P. R., Graham, C. M., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Wilkinson, R. J., Kon, O. M., Banchereau, J., Chaussabel, D., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141421 · Cited by 117
Self-citation
Type I IFN signaling in CD8– DCs impairs Th1-dependent malaria immunity
Haque, A., Best, S. E., de, M. M., James, K. R., Ammerdorffer, A., Edwards, C. L., Rivera, F. D. L., Amante, F. H., Bunn, P. T., Sheel, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70698 · Cited by 111
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Scriba, T. J., Netea, M. G., & Ginsberg, A. M. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101431 · Cited by 116
Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis
Heinonen, S., Jartti, T. T., García, C., Oliva, S., Smitherman, C., Anguiano, E., Piters, W. A. A. D. S., Vuorinen, T., Ruuskanen, O., Dimo, B., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0749oc · Cited by 113
Self-citation
Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy
Tattermusch, S., Skinner, J. A., Chaussabel, D., Banchereau, J., Berry, M. P. R., McNab, F. W., O’Garra, A., Taylor, G. P., & Bangham, C. R. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002480 · Cited by 115
Self-citation
Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [ 18 F]2-Fluoro-Deoxy- d -Glucose Positron Emission Tomography and Computed Tomography
Via, L. E., Schimel, D., Weiner, D. M., Dartois, V. A., Dayao, E. K., Cai, Y., Yoon, Y.-S., Dreher, M. R., Kastenmayer, R. J., Laymon, C. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00531-12 · Cited by 108
Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease
Won, E. J., Choi, J., Cho, Y., Jin, H., Kee, H. J., Park, Y.-W., Kwon, Y. S., & Kee, S. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.11.010 · Cited by 108
Latent tuberculosis infection: Opportunities and challenges
Chee, C. B. E., Reves, R. R., Zhang, Y., & Belknap, R. (2018) · Respirology · doi:10.1111/resp.13346 · Cited by 113
Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes
Howard, N. C., Marín, N. D., Ahmed, M., Rosa, B. A., Martin, J. C., Bambousková, M., Sergushichev, A., Loginicheva, E., Kurepina, N. E., Rangel‐Moreno, J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0245-0 · Cited by 108
Risk of tuberculosis infection in anti-TNF-α biological therapy: From bench to bedside
Xie, X., Li, F., Chen, J., & Wang, J. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.03.005 · Cited by 107
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome
Lai, R., Meintjes, G., & Wilkinson, R. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0532-2 · Cited by 112
Self-citation
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
Rijnink, W. F., Ottenhoff, T. H. M., & Joosten, S. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640168 · Cited by 107
Type I interferons suppress CD4+ T‐cell‐dependent parasite control during blood‐stage Plasmodium infection
Haque, A., Best, S. E., Ammerdorffer, A., Desbarrieres, L., de, M. M., Amante, F. H., Rivera, F. D. L., Hertzog, P. J., Boyle, G. M., Hill, G. R., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141539 · Cited by 107
Systems vaccinology: learning to compute the behavior of vaccine induced immunity
Nakaya, H. I., Li, S., & Pulendran, B. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.163 · Cited by 110
Acquired immunodeficiencies and tuberculosis: focus on HIV / AIDS and diabetes mellitus
Ronacher, K., Joosten, S. A., van Crevel, R., Dockrell, H. M., Walzl, G., & Ottenhoff, T. H. M. (2015) · Immunological Reviews · doi:10.1111/imr.12257 · Cited by 110
Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP+
Krug, A. K., Gutbier, S., Zhao, L., Pöltl, D., Kullmann, C., Ivanova, V., Förster, S., Jagtap, S., Meiser, J., Leparc, G., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.166 · Cited by 111
Neutrophils express pro- and anti-inflammatory cytokines in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques
Gideon, H. P., Phuah, J. Y., Junecko, B. A. F., & Mattila, J. T. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0195-8 · Cited by 106
Deletion of the cyclic di‐AMP phosphodiesterase gene ( cnpB ) in M ycobacterium tuberculosis leads to reduced virulence in a mouse model of infection
Yang, J., Bai, Y., Zhang, Y., Gabrielle, V. D., Jin, L., & Bai, G. (2014) · Molecular Microbiology · doi:10.1111/mmi.12641 · Cited by 107
Host Immune Transcriptional Profiles Reflect the Variability in Clinical Disease Manifestations in Patients with Staphylococcus aureus Infections
Banchereau, R., Jordán-Villegas, A., Ardura, M. I., Mejías, A., Baldwin, N. E., Xu, H., Saye, E. J., Rosselló-Urgell, J., Nguyen, P., Blankenship, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034390 · Cited by 106
Self-citation
The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis
Blankley, S., Graham, C. M., Turner, J., Berry, M. P. R., Bloom, C. I., Xu, Z., Pascual, V., Banchereau, J., Chaussabel, D., Breen, R. A. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162220 · Cited by 105
Self-citation
Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis
Toden, S., Theiss, A. L., Wang, X., & Goel, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-00812-6 · Cited by 106
Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation
Vukmanovic-Stejic, M., Chambers, E. S., Suárez-Fariñas, M., Sandhu, D., Fuentes-Duculan, J., Patel, N., Agius, E., Lacy, K. E., Turner, C. T., Larbi, A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.032 · Cited by 103
Autophagy as an immune effector against tuberculosis
Bradfute, S. B., Castillo, E. F., Arko‐Mensah, J., Chauhan, S., Jiang, S., Mandell, M. A., & Deretic, V. P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.05.003 · Cited by 104
Chronic Bystander Infections and Immunity to Unrelated Antigens
Stelekati, E., & Wherry, E. J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.001 · Cited by 103
Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages
Manna, M. P. L., Orlando, V., Dieli, F., Carlo, P. D., Cascio, A., Cuzzi, G., Palmieri, F., Goletti, D., & Caccamo, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171358 · Cited by 108
A Rab20-Dependent Membrane Trafficking Pathway Controls M. tuberculosis Replication by Regulating Phagosome Spaciousness and Integrity
Schnettger, L., Rodgers, A., Repnik, U., Lai, R., Pei, G., Verdoes, M., Wilkinson, R. J., Young, D., & Gutierrez, M. G. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.004 · Cited by 104
Self-citation
The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy
Stek, C. J., Allwood, B., Walker, N. F., Wilkinson, R. J., Lynen, L., & Meintjes, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02603 · Cited by 105
Self-citation
Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects
Yong, Y. K., Tan, H. Y., Saeidi, A., Wong, W. F., Vignesh, R., Velu, V., Eri, R. D., Larsson, M., & Shankar, E. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02789 · Cited by 102
Neutrophils in Tuberculosis: Heterogeneity Shapes the Way?
Lyadova, I. V. (2017) · Mediators of Inflammation · doi:10.1155/2017/8619307 · Cited by 110
Activated Neutrophils Are Associated with Pediatric Cerebral Malaria Vasculopathy in Malawian Children
Feintuch, C. M., Saidi, A., Seydel, K. B., Chen, G., Goldman-Yassen, A. E., Mita-Mendoza, N. K., Kim, R. S., Frenette, P. S., Taylor, T. E., & Daily, J. P. (2016) · mBio · doi:10.1128/mbio.01300-15 · Cited by 103
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection
de, M. M., Kumar, R., Rivera, F. D. L., Amante, F. H., Sheel, M., Faleiro, R. J., Bunn, P. T., Best, S. E., Beattie, L., Ng, S. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.015 · Cited by 102
Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease
Nathan, A., Beynor, J. I., Baglaenko, Y., Suliman, S., Ishigaki, K., Asgari, S., Huang, C.-C., Luo, Y., Zhang, Z., Lopez, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00933-1 · Cited by 103
Interferons in health and disease
Boehmer, D. F. R., & Zanoni, I. (2025) · Cell · doi:10.1016/j.cell.2025.06.044 · Cited by 112
Host–Pathogen Interactions During Mycobacterium tuberculosis infections
Stanley, S. A., & Cox, J. S. (2013) · Current topics in microbiology and immunology · doi:10.1007/82_2013_332 · Cited by 106

Authors: Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J. J., Mejias, A., Ramilo, O., Kon, O. M., Pascual, V., Banchereau, J., Chaussabel, D., & O’Garra, A.
Affiliations: National Institute for Medical Research (GB)
Inserm (FR)
Imperial College Healthcare NHS Trust (GB)
University of Cape Town (ZA)
The University of Texas Southwestern Medical Center (US)
Baylor Scott & White Health (US)
Nationwide Children's Hospital (US)
Corresponding author: O’Garra, Anne
ORCID: Graham, Christine M.
Xu, Zhaohui
Oni, Tolu
Wilkinson, Katalin A.
Banchereau, Romain
Skinner, Jason
Wilkinson, Robert J.
Quinn, Charles
Dhawan, Ranju
Ramilo, Octavio
Kon, Onn M.
Pascual, Virginia
Banchereau, Jacques
Chaussabel, Damien
O’Garra, Anne
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2010-08
Volume: 466
Issue: 7309
Pages: 973-977
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature09247
PMC: PMC3492754
OpenAlex: W2109543073
Cited by: 1,898
References: 29
Citations by year: 2026: 104 · 2025: 105 · 2024: 112 · 2023: 108 · 2022: 99 · 2021: 121 · 2020: 113 · 2019: 127 · 2018: 137 · 2017: 134 · 2016: 149 · 2015: 126 · 2014: 119 · 2013: 127 · 2012: 114
FWCI: 70.93
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Wellcome Trust (088316, 84323)
Imperial College Healthcare NHS Trust
U.S. Public Health Service (U19 AIO57234-02, P50 ARO54083)
Medical Research Council
National Cancer Institute (P01CA084512)
National Institute of Allergy and Infectious Diseases (U19AI057234, U01AI082110, U19AI082715)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR050770, P50AR054083)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: tuberculosis, Mycobacterium tuberculosis, latent tuberculosis infection, active tuberculosis, whole blood transcriptome, interferon-stimulated genes, neutrophils, interferon-gamma signaling, type I interferon, transcriptomic biomarkers, diagnostic biomarkers, prognostic factors, systemic lupus erythematosus, cell composition, treatment response monitoring
MeSH terms: Blood, Gene Expression Regulation, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Mycobacterium tuberculosis, Neutrophils, Transcription, Genetic, Tuberculosis, Tuberculosis, Pulmonary, Signal Transduction, Case-Control Studies, Gene Expression Profiling, Latent Tuberculosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks